Survey of U.S. reproductive medicine clinicians’ attitudes on polygenic embryo screening

  • Rémy A. Furrer*
  • , Dorit Barlevy
  • , Aayushi Gandhi
  • , Shai Carmi
  • , Todd Lencz
  • , Stacey Pereira
  • , Gabriel Lázaro-Muñoz
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Polygenic embryo screening (PES) is used to screen embryos for their genetic likelihood of developing complex conditions and traits. We surveyed 152 U.S. reproductive endocrinology and infertility specialists (REIs) on their views of PES. While most respondents (97%) were at least slightly familiar with PES, general approval of PES was low (12%), with the majority expressing disapproval (46%) or uncertainty (42%). A majority (58%) believed risks outweigh benefits, while only 16% felt benefits outweigh risks. Most clinicians (85–77%) were very or extremely concerned about low accuracy, confusion over results, false expectations, and eugenics. Nonetheless, when asked to vote on whether PES should be allowed, 44% would vote to allow it, 45% would vote to disallow it, and 10% would abstain from voting. REIs showed more support for PES when used to screen for physical and psychiatric health conditions (59–55% approving) rather than behavioral or physical traits (7–6% approving).

Original languageEnglish
Article number79
Journalnpj Genomic Medicine
Volume10
Issue number1
DOIs
StatePublished - Dec 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Fingerprint

Dive into the research topics of 'Survey of U.S. reproductive medicine clinicians’ attitudes on polygenic embryo screening'. Together they form a unique fingerprint.

Cite this